Related Experiment Video
Updated: Apr 23, 2026

Construction of a Preclinical Multimodality Phantom Using Tissue-mimicking Materials for Quality Assurance in Tumor Size Measurement
Published on: July 29, 2013
Measurement of radiotherapy CBCT dose in a phantom using different methods
1Department of Medical Physics and Radiation Engineering, The Canberra Hospital, Yamba Drive, Garran, ACT, 2605, Australia, naonori.hu@act.gov.au.
Cone beam computed tomography (CBCT) delivers radiation doses that may approach tolerance levels. Independent dosimetry verification is crucial, as measured CBCT doses can significantly exceed manufacturer-stated values.
Area of Science:
- Medical Physics
- Radiation Oncology
- Diagnostic Imaging
Background:
- Cone beam computed tomography (CBCT) is integral to precise patient positioning in modern radiation therapy, particularly for hypofractionated treatments like IMRT and SRT.
- Reported CBCT doses raise concerns about potential radiation tolerance limits for critical organs.
- A lack of standardized CBCT dosimetry protocols necessitates independent verification of manufacturer-stated doses.
Purpose of the Study:
- To investigate and verify dosimetry for CBCT on a Varian Trilogy linear accelerator using established AAPM and IAEA protocols.
- To compare measured CBCT doses with manufacturer-provided values for standard head and body protocols.
- To assess the agreement between multiple dosimetry detection methods.
Main Methods:
- Applied IAEA and AAPM dosimetry approaches to a Varian Trilogy linear accelerator with on-board imager v1.5.
- Utilized three detection methods: 100mm and 300mm pencil ionization chambers, a 0.6 cm³ ionization chamber, and Gafchromic film.
- Performed measurements using custom 45cm and standard 15cm PMMA phantoms simulating head and body exposures.
Main Results:
- Excellent agreement (within 3%) was observed among the different detector systems.
- Measured CBCT doses significantly deviated from Varian's stated doses.
- For the standard head protocol, measured doses were approximately 40% higher than the manufacturer's stated dose.
Conclusions:
- Independent dosimetry verification of CBCT protocols is essential due to potential discrepancies with manufacturer-stated doses.
- The study highlights the critical need for end-users to validate radiation doses delivered by CBCT systems.
- Accurate CBCT dosimetry is vital for ensuring patient safety and optimizing radiation therapy efficacy.
More Related Videos
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021